2023 - Research.com Neuroscience in Spain Leader Award
His primary areas of study are Serotonin, Endocrinology, Internal medicine, Pharmacology and Neuroscience. As part of the same scientific family, he usually focuses on Serotonin, concentrating on Microdialysis and intersecting with Mechanism of action and Autoreceptor. His Endocrinology research is multidisciplinary, relying on both Cerebrospinal fluid, Dorsal raphe nucleus and Receptor antagonist.
His Pharmacology research incorporates elements of NMDA receptor, Receptor, Phencyclidine, Serotonergic and Antidepressant. His Neuroscience and Prefrontal cortex, Dopamine and Neurotransmitter investigations all form part of his Neuroscience research activities. His studies in Raphe nuclei integrate themes in fields like 5-HT1A receptor, Hippocampus and Midbrain Raphe Nuclei.
Francesc Artigas focuses on Neuroscience, Serotonin, Internal medicine, Pharmacology and Endocrinology. His Neuroscience study combines topics in areas such as Serotonergic and Phencyclidine. His Serotonin study is focused on Receptor in general.
His Pharmacology study deals with Antidepressant intersecting with Serotonin transporter, Fluoxetine and Pindolol. His Endocrinology research is multidisciplinary, incorporating perspectives in Agonist, Platelet, Extracellular and Dorsal raphe nucleus. The study incorporates disciplines such as Median raphe nucleus and Postsynaptic potential in addition to Dorsal raphe nucleus.
His primary scientific interests are in Neuroscience, Prefrontal cortex, Pharmacology, Serotonergic and Phencyclidine. His Neuroscience research incorporates themes from NMDA receptor and Glutamate receptor. His study in Pharmacology is interdisciplinary in nature, drawing from both Gene knockdown, Antagonist, Partial agonist, Raphe nuclei and Dorsal raphe nucleus.
His Serotonergic study integrates concerns from other disciplines, such as Hallucinogen and Neurotransmission. The concepts of his Antidepressant study are interwoven with issues in Serotonin transporter, Autoreceptor, Serotonin and 5-HT1A receptor. His Dopamine study is focused on Endocrinology and Internal medicine.
Francesc Artigas focuses on Neuroscience, Antidepressant, Prefrontal cortex, Serotonin and Pharmacology. His Neuroscience study combines topics from a wide range of disciplines, such as Agonist, Serotonergic and 5-HT receptor. His Prefrontal cortex study incorporates themes from Endocrinology, Dopamine, Internal medicine, Premovement neuronal activity and Phencyclidine.
He has included themes like Postsynaptic potential and Neurotransmission in his Serotonin study. His Pharmacology research includes themes of Raphe nuclei and Vilazodone. His work in Raphe nuclei covers topics such as Dorsal raphe nucleus which are related to areas like AMPA receptor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: Involvement of serotonin-1A, GABA(A), and glutamate receptors.
Pau Celada;M. Victoria Puig;Josep M. Casanovas;Gemma Guillazo.
The Journal of Neuroscience (2001)
Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study.
Albert Adell;Francesc Artigas.
Naunyn-schmiedebergs Archives of Pharmacology (1991)
Serotonin 5-HT1A Receptors as Targets for Agents to Treat Psychiatric Disorders: Rationale and Current Status of Research
Pau Celada;Analía Bortolozzi;Francesc Artigas.
CNS Drugs (2013)
Quantitative Analysis of the Expression of Dopamine D1 and D2 Receptors in Pyramidal and GABAergic Neurons of the Rat Prefrontal Cortex
Noemí Santana;Guadalupe Mengod;Francesc Artigas.
Cerebral Cortex (2009)
Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA.
M. Victoria Puig;Francesc Artigas;Pau Celada.
Cerebral Cortex (2004)
The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems.
Albert Adell;Francesc Artigas.
Neuroscience & Biobehavioral Reviews (2004)
Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies.
A.M. Gardier;I. Malagié;A.C. Trillat;C. Jacquot.
Fundamental & Clinical Pharmacology (1996)
Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression.
Dolors Puigdemont;Rosario Pérez-Egea;Maria J. Portella;Joan Molet.
The International Journal of Neuropsychopharmacology (2012)
The activation of 5‐HT2A receptors in prefrontal cortex enhances dopaminergic activity
Analía Bortolozzi;Llorenç Díaz-Mataix;M Cecilia Scorza;Pau Celada.
Journal of Neurochemistry (2005)
Dopaminergic regulation of the serotonergic raphe-striatal pathway: microdialysis studies in freely moving rats
Sergi Ferré;Roser Cortés;Francesc Artigas.
The Journal of Neuroscience (1994)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: